jump to content jump to footer

Structured reports for better patient care in oncology

“mint Lesion™ enables us to make better reports because it truly provides all the necessary data for patient care.”
 
Dr. Laurent Chapuis shares how the software solution mint Lesion™ makes the multitude of initial stagings and follow up assessments for oncology patients they perform at Clinique de la Source Lausanne easier to manage. The “very good approach to tumor assessment” which mint Lesion™ offers, aids clinicians in their treatment of patients and could be integrated into their workflow without disrupting it.

Mint Medical and mediaire strengthen the prostate cancer care pathway with AI-Powered MRI Solutions
Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion…
Read more
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
Read more
scroll-top